USE OF A PLATELET DERIVATIVE FOR STIMULATING CELL PROLIFERATION

(19)

(11)

EP 3 772 537 A8

(12)	CORRECTED EUROPEAN PATENT APPLICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 A1)

(48)	Corrigendum issued on:
	24.03.2021 Bulletin 2021/12

(43)	Date of publication:
	10.02.2021 Bulletin 2021/06

(21)	Application number: 20189880.6

(22)	Date of filing: 06.08.2020

(51)

International Patent Classification (IPC):

C12N 5/00^(2006.01)
C12N 5/077^(2010.01)

G01N 33/50^(2006.01)
A61K 35/16^(2015.01)

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
	Designated Extension States:
	BA ME
	Designated Validation States:
	KH MA MD TN

(30)

Priority:

08.08.2019 IT 201900014430

(71)	Applicant: Medica S.p.A.
	41036 Medolla (IT)

(72)	Inventors:
	MAZZUCCO, Laura 15033 Casale Monferrato (AL) (IT) BOCCHI, Letizia 41036 Medolla (MO) (IT) DI SALVO, Maria Teresa 41036 Medolla (MO) (IT)

(74)	Representative: Casciano, Lidia Giulia Rita et al
	Studio Torta S.p.A. Via Viotti, 9 10121 Torino 10121 Torino (IT)

(54)	USE OF A PLATELET DERIVATIVE FOR STIMULATING CELL PROLIFERATION

(57) The present invention refers to the use of a plasma enriched with platelets and plasma proteins to stimulate cell proliferation and as a supplement for a cell culture medium, and a culture medium comprising said plasma.